Diabetes Does Not Increase Complications, Length of Stay, or Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Diabetes Does Not Increase Complications, Length of Stay, or Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 08; 33(7):E307-E311.

View in: PubMed

subject areas

Cohort Studies
Diabetes Mellitus, Type 2
Female
Hospital Costs
Humans
Illinois
Length of Stay
Lumbosacral Region
Male
Middle Aged
Minimally Invasive Surgical Procedures
Postoperative Complications
Registries
Retrospective Studies
Spinal Fusion
Spondylolisthesis

authors with profiles

Kern Singh